JP Morgan Private Wealth Advisors’s Starling Oncology STLN Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$25.6K	Hold	18,300	–	–	﹤0.01%	1709
2023 Q2	$10.1K	Hold	18,300	–	–	﹤0.01%	1460
2023 Q1	$12.4K	Buy	+18,300	New	+$23.3K	﹤0.01%	1923
2022 Q4	–	Sell	-18,300	Closed	-$85K	–	2003
2022 Q3	$85K	Hold	18,300	–	–	﹤0.01%	1883
2022 Q2	$93K	Hold	18,300	–	–	﹤0.01%	1876
2022 Q1	$130K	Buy	+18,300	New	+$123K	﹤0.01%	1943

Other funds holding STLN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

TAS

TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

JP Morgan Private Wealth Advisors's STLN Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors held its Starling Oncology (STLN) position steady in Q3 2023 at 18,300 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

JP Morgan Private Wealth Advisors first reported a position in STLN in Q1 2022 and has held it in 6 quarters since. The position peaked at $130K in Q1 2022. 36 funds tracked by Wall St. Rank hold STLN as of Q3 2023.

JP Morgan Private Wealth Advisors held 18,300 shares of Starling Oncology worth $25.6K as of Q3 2023.
JP Morgan Private Wealth Advisors left its Starling Oncology share count unchanged in Q3 2023.
Starling Oncology made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1709 holding.
JP Morgan Private Wealth Advisors first reported a position in Starling Oncology in Q1 2022 and has held it in 6 quarters since.
JP Morgan Private Wealth Advisors's Starling Oncology position peaked at $130K in Q1 2022.
36 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.